ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,586Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 3647

$1.15M Total Retail Price of All Prescriptions

Rank: 158 out of 3647

1,408 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,408 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 1,408 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 22,134 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,394 902 S3 1 12
LISINOPRIL 1,232 977 2 4
AMLODIPINE BESYLATE 1,141 918 3 2
OMEPRAZOLE 1,104 861 4 3
LEVOTHYROXINE SODIUM 1,066 893 5 5
LOVASTATIN 953 828 6 21
SIMVASTATIN 860 688 7 1
HYDROCHLOROTHIAZIDE 815 714 8 9
METFORMIN HCL 739 637 9 6
FUROSEMIDE 703 492 10 8
METOPROLOL TARTRATE 643 527 11 7
GABAPENTIN 545 394 12 17
FENOFIBRATE 419 332 13 50
LOSARTAN POTASSIUM 372 319 14 11
ALENDRONATE SODIUM 347 326 15 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 336 290 16 36
IBUPROFEN 323 203 17 55
PRAVASTATIN SODIUM 322 233 18 16
ZOLPIDEM TARTRATE 296 203 19 14
CIPROFLOXACIN HCL 279 205 20 53
GEMFIBROZIL 251 204 21 82
TRAMADOL HCL 248 212 22 22
ATENOLOL 245 189 23 10
CARVEDILOL 238 165 24 20
POTASSIUM CHLORIDE 217 153 25 24
PROAIR HFA 216 127 26 62
MELOXICAM 215 145 27 33
WARFARIN SODIUM 212 154 28 15
CITALOPRAM HBR 211 137 29 25
CLOPIDOGREL 209 163 30 26
RANITIDINE HCL 196 143 31 29
SERTRALINE HCL 195 135 32 27
OXYBUTYNIN CHLORIDE 191 144 33 107
ALLOPURINOL 190 147 34 37
ADVAIR DISKUS 180 131 35 52
TIZANIDINE HCL 180 122 35 126
VENTOLIN HFA 176 99 37 88
DONEPEZIL HCL 174 156 38 30
CLONIDINE HCL 172 144 39 46
PLAVIX 171 139 40 39
TAMSULOSIN HCL 169 138 41 28
ALPRAZOLAM 166 116 42 31
GLYBURIDE 166 144 R 42 54
ATORVASTATIN CALCIUM 164 121 44 13
FINASTERIDE 161 129 45 66
NAPROXEN 158 133 46 70
OXYCODONE HCL-ACETAMINOPHEN 157 72 S2 47 104
PAROXETINE HCL 157 130 47 60
TERAZOSIN HCL 156 136 49 103
METOPROLOL SUCCINATE 150 134 50 18
GLIPIZIDE 149 123 51 41
AZITHROMYCIN 142 105 52 34
FLUTICASONE PROPIONATE 138 88 53 32
SPIRIVA 136 92 54 93
MECLIZINE HCL 135 104 55 85
CYCLOBENZAPRINE HCL 135 67 R 55 98
ENALAPRIL MALEATE 134 103 57 35
HYDRALAZINE HCL 124 88 58 81
GLIMEPIRIDE 124 113 58 45
SINGULAIR 123 66 60 90
AMOXICILLIN 123 99 60 133
VERAPAMIL ER 122 110 62 99
LOSARTAN-HYDROCHLOROTHIAZIDE 122 117 62 48
DICLOFENAC SODIUM 117 74 64 86
LANTUS SOLOSTAR 112 66 65 124
CRESTOR 111 79 66 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 111 90 66 110
LANTUS 105 53 68 59
DIOVAN 104 80 69 40
OXYCODONE-ACETAMINOPHEN 100 74 S2 70 91
CEPHALEXIN 100 78 70 142
CALCITRIOL 97 70 72 265
TRAZODONE HCL 95 44 73 64
LYRICA 91 45 74 120
SPIRONOLACTONE 89 48 75 77
NEXIUM 87 58 76 44
BENAZEPRIL HCL 87 74 76 71
AMITRIPTYLINE HCL 86 52 R 78 105
ROPINIROLE HCL 84 46 79 151
FLUOXETINE HCL 83 53 80 68
RAMIPRIL 82 63 81 101
SYNTHROID 78 70 82 42
FLUCONAZOLE 78 44 82 226
KLOR-CON 10 77 59 84 106
NAMENDA 77 75 84 49
AMOX TR-POTASSIUM CLAVULANATE 75 39 86 118
PROPRANOLOL HCL 74 48 87 156
DILTIAZEM ER 73 67 88 167
DIOVAN HCT 73 50 88 80
PEN NEEDLE 70 36 90 166
COLCRYS 70 57 90 313
ENDOCET 70 27 S2 90 269
METHYLPREDNISOLONE 67 51 93 78
NIFEDIPINE ER 66 62 94 67
TRIAMCINOLONE ACETONIDE 66 58 94 136
ISOSORBIDE MONONITRATE ER 66 45 94 56
CARISOPRODOL 66 0 R 94 115
CYMBALTA 64 38 98 79
PANTOPRAZOLE SODIUM 64 50 98 38
METHOCARBAMOL 64 20 R 98 250
PREDNISONE 63 32 101 43
TRICOR 62 51 102 144
CILOSTAZOL 61 61 103 168
SYMBICORT 60 27 104 153
LIPITOR 59 37 105 113
NATEGLINIDE 56 56 106 339
PREMARIN 55 34 R 107 217
LORAZEPAM 54 49 108 73
CELEBREX 53 50 109 111
CAPTOPRIL 53 50 109 193
MONTELUKAST SODIUM 51 32 111 160
HYDROXYZINE HCL 51 47 R 111 244
TRIAMTERENE-HCTZ 50 47 113 58
GLIPIZIDE ER 50 39 113 112
KLOR-CON M20 50 37 113 121
INSULIN SYRINGE 50 32 113 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.